228 related articles for article (PubMed ID: 23494229)
1. Effects of an epilepsy-causing mutation in the SCN1A sodium channel gene on cocaine-induced seizure susceptibility in mice.
Purcell RH; Papale LA; Makinson CD; Sawyer NT; Schroeder JP; Escayg A; Weinshenker D
Psychopharmacology (Berl); 2013 Jul; 228(2):263-70. PubMed ID: 23494229
[TBL] [Abstract][Full Text] [Related]
2. Neuronal voltage-gated ion channels are genetic modifiers of generalized epilepsy with febrile seizures plus.
Hawkins NA; Martin MS; Frankel WN; Kearney JA; Escayg A
Neurobiol Dis; 2011 Mar; 41(3):655-60. PubMed ID: 21156207
[TBL] [Abstract][Full Text] [Related]
3. Scn1a dysfunction alters behavior but not the effect of stress on seizure response.
Sawyer NT; Helvig AW; Makinson CD; Decker MJ; Neigh GN; Escayg A
Genes Brain Behav; 2016 Mar; 15(3):335-47. PubMed ID: 26694226
[TBL] [Abstract][Full Text] [Related]
4. Altered sleep regulation in a mouse model of SCN1A-derived genetic epilepsy with febrile seizures plus (GEFS+).
Papale LA; Makinson CD; Christopher Ehlen J; Tufik S; Decker MJ; Paul KN; Escayg A
Epilepsia; 2013 Apr; 54(4):625-34. PubMed ID: 23311867
[TBL] [Abstract][Full Text] [Related]
5. Preferential inactivation of Scn1a in parvalbumin interneurons increases seizure susceptibility.
Dutton SB; Makinson CD; Papale LA; Shankar A; Balakrishnan B; Nakazawa K; Escayg A
Neurobiol Dis; 2013 Jan; 49():211-20. PubMed ID: 22926190
[TBL] [Abstract][Full Text] [Related]
6. Altered function of the SCN1A voltage-gated sodium channel leads to gamma-aminobutyric acid-ergic (GABAergic) interneuron abnormalities.
Martin MS; Dutt K; Papale LA; Dubé CM; Dutton SB; de Haan G; Shankar A; Tufik S; Meisler MH; Baram TZ; Goldin AL; Escayg A
J Biol Chem; 2010 Mar; 285(13):9823-9834. PubMed ID: 20100831
[TBL] [Abstract][Full Text] [Related]
7. Role of the hippocampus in Nav1.6 (Scn8a) mediated seizure resistance.
Makinson CD; Tanaka BS; Lamar T; Goldin AL; Escayg A
Neurobiol Dis; 2014 Aug; 68():16-25. PubMed ID: 24704313
[TBL] [Abstract][Full Text] [Related]
8. The voltage-gated sodium channel Scn8a is a genetic modifier of severe myoclonic epilepsy of infancy.
Martin MS; Tang B; Papale LA; Yu FH; Catterall WA; Escayg A
Hum Mol Genet; 2007 Dec; 16(23):2892-9. PubMed ID: 17881658
[TBL] [Abstract][Full Text] [Related]
9. An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior.
Makinson CD; Dutt K; Lin F; Papale LA; Shankar A; Barela AJ; Liu R; Goldin AL; Escayg A
Exp Neurol; 2016 Jan; 275 Pt 1(0 1):46-58. PubMed ID: 26410685
[TBL] [Abstract][Full Text] [Related]
10. Early-life febrile seizures worsen adult phenotypes in Scn1a mutants.
Dutton SBB; Dutt K; Papale LA; Helmers S; Goldin AL; Escayg A
Exp Neurol; 2017 Jul; 293():159-171. PubMed ID: 28373025
[TBL] [Abstract][Full Text] [Related]
11. A two-hit story: Seizures and genetic mutation interaction sets phenotype severity in SCN1A epilepsies.
Salgueiro-Pereira AR; Duprat F; Pousinha PA; Loucif A; Douchamps V; Regondi C; Ayrault M; Eugie M; Stunault MI; Escayg A; Goutagny R; Gnatkovsky V; Frassoni C; Marie H; Bethus I; Mantegazza M
Neurobiol Dis; 2019 May; 125():31-44. PubMed ID: 30659983
[TBL] [Abstract][Full Text] [Related]
12. Scn1a and Cacna1a mutations mutually alter their original phenotypes in rats.
Ohmori I; Kobayashi K; Ouchida M
Neurochem Int; 2020 Dec; 141():104859. PubMed ID: 33045260
[TBL] [Abstract][Full Text] [Related]
13. A BAC transgenic mouse model reveals neuron subtype-specific effects of a Generalized Epilepsy with Febrile Seizures Plus (GEFS+) mutation.
Tang B; Dutt K; Papale L; Rusconi R; Shankar A; Hunter J; Tufik S; Yu FH; Catterall WA; Mantegazza M; Goldin AL; Escayg A
Neurobiol Dis; 2009 Jul; 35(1):91-102. PubMed ID: 19409490
[TBL] [Abstract][Full Text] [Related]
14. A Transient Developmental Window of Fast-Spiking Interneuron Dysfunction in a Mouse Model of Dravet Syndrome.
Favero M; Sotuyo NP; Lopez E; Kearney JA; Goldberg EM
J Neurosci; 2018 Sep; 38(36):7912-7927. PubMed ID: 30104343
[TBL] [Abstract][Full Text] [Related]
15. Interneuron Dysfunction in a New Mouse Model of SCN1A GEFS.
Das A; Zhu B; Xie Y; Zeng L; Pham AT; Neumann JC; Safrina O; Benavides DR; MacGregor GR; Schutte SS; Hunt RF; O'Dowd DK
eNeuro; 2021; 8(2):. PubMed ID: 33658306
[TBL] [Abstract][Full Text] [Related]
16. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.
Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA
PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696
[TBL] [Abstract][Full Text] [Related]
17. Seizure Phenotype and Underlying Cellular Defects in
Roemmich AJ; Vu T; Lukacsovich T; Hawkins C; Schutte SS; O'Dowd DK
eNeuro; 2021; 8(5):. PubMed ID: 34475263
[TBL] [Abstract][Full Text] [Related]
18. Sexually Divergent Mortality and Partial Phenotypic Rescue After Gene Therapy in a Mouse Model of Dravet Syndrome.
Niibori Y; Lee SJ; Minassian BA; Hampson DR
Hum Gene Ther; 2020 Mar; 31(5-6):339-351. PubMed ID: 31830809
[TBL] [Abstract][Full Text] [Related]
19. NaV1.1 channels and epilepsy.
Catterall WA; Kalume F; Oakley JC
J Physiol; 2010 Jun; 588(Pt 11):1849-59. PubMed ID: 20194124
[TBL] [Abstract][Full Text] [Related]
20. Soticlestat, a novel cholesterol 24-hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome mice.
Hawkins NA; Jurado M; Thaxton TT; Duarte SE; Barse L; Tatsukawa T; Yamakawa K; Nishi T; Kondo S; Miyamoto M; Abrahams BS; During MJ; Kearney JA
Epilepsia; 2021 Nov; 62(11):2845-2857. PubMed ID: 34510432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
